Izotropic Corporation Closes $375,000 Private Placement to Advance Breast Cancer Imaging Technology

Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) has completed a non-brokered private placement raising $375,000 through the issuance of 1.5 million units at $0.25 per unit. Each unit consists of one common share and one transferable warrant exercisable at $0.50 per share for a period of three years. The company, which focuses on developing imaging-based products for more accurate breast cancer screening, diagnosis, and treatment, will allocate the proceeds toward general working capital requirements.

The financing included participation from an insider who acquired 100,000 units under exemptions from MI 61-101 requirements, demonstrating internal confidence in the company's direction. In connection with the offering, Izotropic paid $3,500 and issued 14,000 broker warrants exercisable at $0.25 per share for three years. This funding comes at a critical time for medical device companies working on innovative cancer detection technologies, where adequate capital is essential for research, development, and regulatory advancement.

For investors seeking additional information, the company maintains its profile on SEDAR at https://sedarplus.ca where financial disclosures and corporate updates are regularly filed. The successful closure of this private placement enables Izotropic to continue its mission of improving breast cancer outcomes through advanced imaging solutions, potentially addressing significant gaps in current screening methodologies that affect millions of women worldwide.

The broader implications of this funding extend beyond immediate financial stability, as it supports ongoing efforts to enhance the accuracy and accessibility of breast cancer diagnostics. Early and precise detection remains a cornerstone of effective cancer treatment, and investments in companies like Izotropic contribute to the evolution of medical technology that could reduce false positives, improve patient outcomes, and lower healthcare costs. More details about the company's initiatives can be found on its official website at https://izocorp.com.